Related Experiment Video
Updated: Feb 25, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
Practical Management of Cardiovascular Comorbidities in Rheumatoid Arthritis
Roberta Gualtierotti1, Nicola Ughi2, Giovanni Marfia3
1Division of Rheumatology, ASST Pini, Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy. roberta.gualtierotti@unimi.it.
Insights
Rheumatoid arthritis (RA) patients frequently develop cardiovascular comorbidities like accelerated atherosclerosis. This review proposes a practical approach for cardiovascular risk assessment and management in RA, addressing gaps in current clinical guidelines.
Area of Science:
- Rheumatology
- Cardiology
- Immunology
Background:
- Cardiovascular (CV) comorbidities are common in rheumatoid arthritis (RA).
- Accelerated atherosclerosis leading to cardiovascular disease (CVD) is a significant cause of mortality in RA patients.
- Subclinical CVD can manifest early in RA, influenced by both traditional and non-traditional CV risk factors.
Purpose of the Study:
- To propose a practical approach for CV risk assessment and management in RA patients.
- To address the lack of clear guidelines for CV risk stratification and intervention in RA.
- To synthesize available evidence for managing CVD in the context of RA.
Main Methods:
- Review of available evidence on CV comorbidities in RA.
- Analysis of traditional and non-traditional CV risk factors in RA pathogenesis.
- Synthesis of current understanding of subclinical CVD in early RA.
Main Results:
- Cardiovascular disease is a major concern in RA, linked to accelerated atherosclerosis.
- Both traditional and non-traditional risk factors contribute to RA-related CVD.
- Current evidence is insufficient for definitive CV risk assessment tools and interventions in RA.
Conclusions:
- A practical approach is proposed for CV risk assessment and management in RA.
- Further research, including randomized clinical trials, is needed to refine strategies.
- Early identification and management of subclinical CVD are crucial in RA patients.
Abstract:
Cardiovascular (CV) comorbidities are a frequent extra-articular manifestation of rheumatoid arthritis (RA). Cardiovascular disease (CVD) with accelerated atherosclerosis is a major cause of morbidity and mortality in patients with RA. Subclinical CVD may be present since the early phase of RA. Not only traditional but also non-traditional CV risk factors are involved in the pathogenesis of RA-related CVD. Due to the lack of specifically designed randomized clinical trials, it is still unclear which tools to use to perform CV risk assessment, how to interpret the results and which interventions are appropriate in RA patients both to prevent and to manage CVD. Based on the available evidence, we propose a practical approach.
Related Concept Videos
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease IV: Nursing Management
Atherosclerosis III: Management
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Pericarditis III: Medical Management

